ONVO 1 (-2.91%)
US68620A2033Medical Diagnostics & ResearchDiagnostics & Research

Organovo Holdings (ONVO) Competitor Comparison

We are evaluating the key criteria listed to compare Organovo Holdings (ONVO) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - ONVO ranking 51 / 58

These are the competitors of Organovo Holdings in the industry Diagnostics & Research ranked by linearity 5 years
1. Qiagen QGEN
114.06
2. Co-Diagnostics CODX
86.1
3. DarioHealth DRIO
37.07
4. Ortho Clinical Diagnostics Holdings OCDX
33.4
5. Syneos Health SYNH
24.79
6. Twist Bioscience TWST
24.06
7. National Research NRC
16.29
8. Heska HSKA
15.42
9. NeoGenomics NEO
9.01
10. Inotiv NOTV
8.04
11. Anixa Biosciences ANIX
7.75
12. Quest Diagnostics DGX
7.06
13. Exact Sciences EXAS
6.29
14. Waters WAT
5.96
15. Fulgent Genetics FLGT
5.69
16. Sera Prognostics SERA
5.49
17. Pacific Biosciences of California PACB
5.17
18. Trinity Biotech TRIB
5.07
19. PerkinElmer PKI
4.97
20. Laboratory Corp of America Holdings LH
4.85
21. SeqLL SQL
4.82
22. CareDx CDNA
4.7
23. Aspira Womens Health AWH
4.61
24. Neogen NEOG
4.54
25. Myriad Genetics MYGN
4.48
26. Charles River Laboratories CRL
4.35
27. Mettler-Toledo MTD
4.02
28. Guardant Health GH
4
29. Olink Holding OLK
3.95
30. Illumina ILMN
3.86
31. IQVIA Holdings IQV
3.41
32. Sotera Health SHC
3.39
33. Danaher DHR
3.32
34. Agilent Technologies A
3.27
35. Enzo Biochem ENZ
3.12
36. Interpace Biosciences IDXG
2.58
37. IDEXX Laboratories IDXX
2.51
38. Thermo Fisher Scientific TMO
2.5
39. Psychemedics PMD
2.35
40. Global Cord Blood CO
2.23
41. Exagen XGN
2.21
42. MDxHealth MDXH
2.18
43. Bioventus BVS
2.15
44. MaxCyte MXCT
2.14
45. Biodesix BDSX
2.02
46. Neuronetics STIM
2.01
47. Prenetics Global PRE
1.94
48. Personalis PSNL
1.88
49. Icon ICLR
1.76
50. bioAffinity Technologies BIAF
1.75
51. Organovo Holdings ONVO
1.62
52. Precipio PRPO
1.52
53. Lantheus Holdings LNTH
1.2
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.91
56. DexCom DXCM
0.84
57. RadNet RDNT
0.43
58. Medpace Holdings MEDP
0.24

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.